Page 2225 of 9001
Tevogen Bio begins pre-clinical effort for TVGN 920, signaling the start of its oncology treatment pipeline.Tevogen Bio created a data set containing known proteins in the HPV genome to identify targets, accelerating the pre-clinical process.5.5 million women per year have HPV 16/18; of these 200,000 women per year are diagnosed with high grade dysplasia. WARREN, N.J., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specia...
Continue Reading
Apple is facing headwinds from Chinaâs weak consumption and U.S.-China tensions. Read why AAPL stock could see declines due to its share loss in China...
Continue ReadingApple and Dell Technologies are part of the Zacks Industry Outlook article...
Continue ReadingAs the adoption of cryptocurrency increases, major American companies are incorporating Bitcoin onto their balance sheet as an investment and store of value...
Continue Reading
Zacks.com users have recently been watching Microsoft (MSFT) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects...
Continue ReadingZacks.com users have recently been watching Apple (AAPL) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects...
Continue ReadingThe consumer advocacy group Which? assessed several popular types of smart gadgets over data and privacy...
Continue ReadingWhile Wall Street reacted positively to Alphabet’s (GOOGL) Q3 results, I believe shares remain undervalued, presenting a compelling opportunity today. Alphabet’s core business segments, like Google Search and YouTube, remained robust and displayed impressive growth in Q3. However, the true highlight of the report was Google Cloud, which not only recorded a notable acceleration in revenue growth but also saw substantial operating income gains. Yet, Alphabet’s valuation doesn’t seem to fully refle...
Continue ReadingWarren Buffett’s Berkshire Hathaway (BRK.A) grew its cash pile to a record $325.2 billion in the third quarter. That’s enough to buy some of the biggest companies in the world — with cash to spare...
Continue ReadingPalantir's intrinsic EV is estimated at $46.06b, indicating a 49% negative margin of safety from its current EV of $90.23b. Learn more about PLTR stock here...
Continue Reading